Faculty and Academic Staff
Professor Ann Hsing, PhD, MPH
ANN HSING, PhD, MPH, is an epidemiologist with over 28 years of experience in cancer epidemiology, genetic and molecular epidemiology, population sciences, and international studies. She has extensive expertise in hepatobiliary and prostate cancer epidemiology, hormonal carcinogenesis, genetic susceptibility, circadian rhythms, and inflammation.
She is a professor in the Department of Medicine, Stanford School of Medicine, a co-leader of the Population Sciences Program, Stanford Cancer Institute (SCI), and a faculty fellow at the Center for Innovation in Global Health. At Stanford, Dr. Hsing leads the Liver Cancer Working Group and the Low Dose CT (LDCT) Working Group and chairs the Pacific Rim Alliance for Population Health (PRAPH) at the Center for Population Health Sciences (PHS). Prior to joining Stanford, Dr. Hsing was a tenured senior investigator at the National Cancer Institute for 22 years, and from 2012-2015 she served as the Chief Scientific Officer of the Cancer Prevention Institute of California, a consortium partner of SCI. Dr. Hsing has conducted population-based epidemiological studies on four continents, including North and South America, Asia, and Africa. She has served on numerous committees and advisory boards, most recently as a member of the Editorial Board of Cancer Epidemiology, Biomarkers and Prevention and as an academic editor of PLOS ONE. She is an elected fellow of the American Epidemiological Society and American College of Epidemiology. Hsing has authored more than 270 peer-reviewed articles, written seven book chapters, and mentored over 50 fellows and scholars. At Stanford Prevention Research Center, Dr. Hsing serves as the PI for three WELL cohorts, including WELL China, WELL Singapore, and WELL Taiwan